Risk factors for clinical treatment failure regarding carbapenem-resistant Enterobacterales in the southwestern United States

  • 0Department of Pharmacy, Banner University Medical Center, Phoenix, AZ, USA.

|

|

Summary

This summary is machine-generated.

Carbapenem-resistant Enterobacterales (CRE) infections are rising, with New Delhi metallo-beta-lactamases (NDM) becoming more common in the Southwest US. Risk factors for treatment failure include ICU admission and prior hospitalization.

Area Of Science

  • Infectious Diseases
  • Microbiology
  • Public Health

Background

  • Carbapenem-resistant Enterobacterales (CRE) infections pose a growing threat in the US, causing significant illness and death.
  • Klebsiella pneumoniae carbapenemases (KPC) were historically dominant, but regional shifts in carbapenemase types are occurring.

Purpose Of The Study

  • To investigate the changing epidemiology of CRE in the southwestern United States.
  • To identify risk factors associated with treatment failure in CRE infections.

Main Methods

  • A retrospective observational study was conducted across 33 acute care hospitals in the southwestern US.
  • Data from 169 patients aged 18 or older with carbapenem-resistant infections between January 1, 2023, and July 31, 2023, were analyzed.

Main Results

  • Klebsiella pneumoniae was the most prevalent CRE species (82%), with metallo beta-lactamases (MBLs), particularly New Delhi metallo-beta-lactamases (NDMs), being the most common carbapenemase (76%).
  • Independent risk factors for treatment failure included renal replacement therapy (OR 2.44), prior hospitalization within 90 days (OR 2.69), and ICU admission (OR 5.55).

Conclusions

  • The study reveals a concerning increase in NDM-producing CRE in the southwestern US, especially Arizona.
  • Close evaluation of patient risk factors is crucial for selecting effective empiric therapy against CRE infections.